Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[A novel immune system]

M Taniguchi1, H Sato, J Cui

  • 1Division of Molecular Immunology, School of Medicine Chiba University.

Arerugi = [Allergy]
|March 21, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neutralizing activity of human antibodies against the structural protein of human T-cell lymphotropic virus type I.

International journal of cancer·1992
Same author

Identification of one base deletion in exon IX of the protein C gene that causes a type I deficiency.

Thrombosis research·1992
Same author

Evaluation of an improved dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge in early breast cancer: results of a multicenter study.

Japanese journal of clinical oncology·1992
Same author

Transfer of plutonium to rat embryos in vivo and in vitro.

Journal of radiation research·1992
Same author

Purification of a new anticoagulant protein, calphobindin III, from human placenta.

The Tohoku journal of experimental medicine·1992
Same author

Inhibition of active oxygen generation by dipyridamole in human polymorphonuclear leukocytes.

European journal of pharmacology·1992
Same journal

Arerugi = [Allergy]·2026
Same journal

Arerugi = [Allergy]·2026
Same journal

Arerugi = [Allergy]·2026
Same journal

Arerugi = [Allergy]·2026
Same journal

Arerugi = [Allergy]·2026
Same journal

Arerugi = [Allergy]·2026
See all related articles

Researchers discovered a novel V alpha 14 NKT cell lineage essential for IL-12-mediated tumor rejection. These cells develop extrathymically and require invariant V alpha 14 TCR for their generation.

Area of Science:

  • Immunology
  • Cell Biology

Context:

  • Identification of a unique lymphocyte population.
  • Characterization of invariant T cell receptor (TCR) expression.

Purpose:

  • To define a novel lymphoid cell lineage, V alpha 14 NKT cells.
  • To elucidate the developmental requirements and function of these cells.

Summary:

  • A novel V alpha 14 NKT cell lineage was identified, marked by NK1.1 and invariant TCR expression, unique phenotypes, and extrathymic development.
  • The invariant V alpha 14 TCR is crucial for NKT cell development, as demonstrated by gene deletion and transgenic studies.
  • V alpha 14 NKT cells are primary targets of IL-12 in tumor rejection, distinct from NK and T cells.

Impact:

Related Experiment Videos

  • Establishes V alpha 14 NKT cells as a distinct lineage with critical roles in immunity.
  • Highlights the importance of invariant TCRs in lymphocyte development.
  • Identifies V alpha 14 NKT cells as key mediators in IL-12-driven anti-tumor responses.